Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 735.2K | 759.7K | +24.5K (+3.3%) |
| Value | $1.40M | $2.27M | +$875.4K (+62.7%) |
New holders (2)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Measured Wealth Private Client Group, LLC | 1,000 | $2.98K | 0.00% |
| Barclays PLC | 6 | $18 | 0.00% |
Sold out (3)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Two Sigma Securities, LLC | 13,104 | $24.9K |
| CWM, LLC | 1,000 | $2.00K |
| Raymond James Financial Inc | 1,000 | $1.90K |